These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


882 related items for PubMed ID: 19409967

  • 21. Anti-apoptotic and neuroprotective effects of edaravone following transient focal ischemia in rats.
    Amemiya S, Kamiya T, Nito C, Inaba T, Kato K, Ueda M, Shimazaki K, Katayama Y.
    Eur J Pharmacol; 2005 Jun 01; 516(2):125-30. PubMed ID: 15921675
    [Abstract] [Full Text] [Related]

  • 22. Attenuation of axonal injury and oxidative stress by edaravone protects against cognitive impairments after traumatic brain injury.
    Ohta M, Higashi Y, Yawata T, Kitahara M, Nobumoto A, Ishida E, Tsuda M, Fujimoto Y, Shimizu K.
    Brain Res; 2013 Jan 15; 1490():184-92. PubMed ID: 22982593
    [Abstract] [Full Text] [Related]

  • 23. MCI-186 reduces oxidative cellular damage and increases DNA repair function in the rabbit spinal cord after transient ischemia.
    Takahashi G, Sakurai M, Abe K, Itoyama Y, Tabayashi K.
    Ann Thorac Surg; 2004 Aug 15; 78(2):602-7. PubMed ID: 15276530
    [Abstract] [Full Text] [Related]

  • 24. Edaravone alleviates delayed neuronal death and long-dated cognitive dysfunction of hippocampus after transient focal ischemia in Wistar rat brains.
    Jiao L, Zhang J, Li Z, Liu H, Chen Y, Xu S.
    Neuroscience; 2011 May 19; 182():177-83. PubMed ID: 21241778
    [Abstract] [Full Text] [Related]

  • 25. Edaravone attenuates cerebral ischemic injury by suppressing aquaporin-4.
    Kikuchi K, Tancharoen S, Matsuda F, Biswas KK, Ito T, Morimoto Y, Oyama Y, Takenouchi K, Miura N, Arimura N, Nawa Y, Meng X, Shrestha B, Arimura S, Iwata M, Mera K, Sameshima H, Ohno Y, Maenosono R, Tajima Y, Uchikado H, Kuramoto T, Nakayama K, Shigemori M, Yoshida Y, Hashiguchi T, Maruyama I, Kawahara K.
    Biochem Biophys Res Commun; 2009 Dec 25; 390(4):1121-5. PubMed ID: 19737535
    [Abstract] [Full Text] [Related]

  • 26. Postischemic administration of Z-Ligustilide ameliorates cognitive dysfunction and brain damage induced by permanent forebrain ischemia in rats.
    Kuang X, Du JR, Liu YX, Zhang GY, Peng HY.
    Pharmacol Biochem Behav; 2008 Jan 25; 88(3):213-21. PubMed ID: 17889286
    [Abstract] [Full Text] [Related]

  • 27. Neuroprotective effects of the free radical scavenger Edaravone (MCI-186) in mice permanent focal brain ischemia.
    Shichinohe H, Kuroda S, Yasuda H, Ishikawa T, Iwai M, Horiuchi M, Iwasaki Y.
    Brain Res; 2004 Dec 17; 1029(2):200-6. PubMed ID: 15542075
    [Abstract] [Full Text] [Related]

  • 28. Protective effects of edaravone on experimental spinal cord injury in rats.
    Ozgiray E, Serarslan Y, Oztürk OH, Altaş M, Aras M, Söğüt S, Yurtseven T, Oran I, Zileli M.
    Pediatr Neurosurg; 2011 Dec 17; 47(4):254-60. PubMed ID: 22310070
    [Abstract] [Full Text] [Related]

  • 29. Minocycline alleviates hypoxic-ischemic injury to developing oligodendrocytes in the neonatal rat brain.
    Cai Z, Lin S, Fan LW, Pang Y, Rhodes PG.
    Neuroscience; 2006 Dec 17; 137(2):425-35. PubMed ID: 16289838
    [Abstract] [Full Text] [Related]

  • 30. Intensity of chronic cerebral hypoperfusion determines white/gray matter injury and cognitive/motor dysfunction in mice.
    Miki K, Ishibashi S, Sun L, Xu H, Ohashi W, Kuroiwa T, Mizusawa H.
    J Neurosci Res; 2009 Apr 17; 87(5):1270-81. PubMed ID: 18951530
    [Abstract] [Full Text] [Related]

  • 31. Pre-treatment and post-treatment with alpha-tocopherol attenuates hippocampal neuronal damage in experimental cerebral hypoperfusion.
    Annaházi A, Mracskó E, Süle Z, Karg E, Penke B, Bari F, Farkas E.
    Eur J Pharmacol; 2007 Oct 01; 571(2-3):120-8. PubMed ID: 17597609
    [Abstract] [Full Text] [Related]

  • 32. Neuroprotection of edaravone on hypoxic-ischemic brain injury in neonatal rats.
    Yasuoka N, Nakajima W, Ishida A, Takada G.
    Brain Res Dev Brain Res; 2004 Jul 19; 151(1-2):129-39. PubMed ID: 15246699
    [Abstract] [Full Text] [Related]

  • 33. Edaravone, a free radical scavenger, attenuates behavioral deficits following transient forebrain ischemia by inhibiting oxidative damage in gerbils.
    Lu F, Nakamura T, Toyoshima T, Liu Y, Hirooka K, Kawai N, Okabe N, Shiraga F, Tamiya T, Miyamoto O, Keep RF, Itano T.
    Neurosci Lett; 2012 Jan 06; 506(1):28-32. PubMed ID: 22040669
    [Abstract] [Full Text] [Related]

  • 34. Edaravone, a newly developed radical scavenger, protects against ischemia-reperfusion injury of the small intestine in rats.
    Tomatsuri N, Yoshida N, Takagi T, Katada K, Isozaki Y, Imamoto E, Uchiyama K, Kokura S, Ichikawa H, Naito Y, Okanoue T, Yoshikawa T.
    Int J Mol Med; 2004 Jan 06; 13(1):105-9. PubMed ID: 14654979
    [Abstract] [Full Text] [Related]

  • 35. Combination drug therapy using edaravone and Daio-Orengedoku-to after transient focal ischemia in rats.
    Cho KH, Oh JK, Jang YS, Jung JW, Oh HR, Park EK, Kim DH, Moon SK, Kim DH, Ryu JH.
    Methods Find Exp Clin Pharmacol; 2008 Jan 06; 30(6):443-50. PubMed ID: 18850045
    [Abstract] [Full Text] [Related]

  • 36. Edaravone protects against ischemia/reperfusion-induced functional and biochemical changes in rat urinary bladder.
    Matsumoto S, Hanai T, Yoshioka N, Shimizu N, Sugiyama T, Uemura H, Levin RM.
    Urology; 2005 Oct 06; 66(4):892-6. PubMed ID: 16230177
    [Abstract] [Full Text] [Related]

  • 37. Free radical scavenger, edaravone, in stroke with internal carotid artery occlusion.
    Toyoda K, Fujii K, Kamouchi M, Nakane H, Arihiro S, Okada Y, Ibayashi S, Iida M.
    J Neurol Sci; 2004 Jun 15; 221(1-2):11-7. PubMed ID: 15178207
    [Abstract] [Full Text] [Related]

  • 38. Preventive and curative effect of edaravone on nerve functions and oxidative stress in experimental diabetic neuropathy.
    Saini AK, Kumar H S A, Sharma SS.
    Eur J Pharmacol; 2007 Jul 30; 568(1-3):164-72. PubMed ID: 17521626
    [Abstract] [Full Text] [Related]

  • 39. Experimental study on the protective effects of edaravone against ischemic spinal cord injury.
    Suzuki K, Kazui T, Terada H, Umemura K, Ikeda Y, Bashar AH, Yamashita K, Washiyama N, Suzuki T, Ohkura K, Yasuike J.
    J Thorac Cardiovasc Surg; 2005 Dec 30; 130(6):1586-92. PubMed ID: 16308003
    [Abstract] [Full Text] [Related]

  • 40. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum.
    Kawasaki T, Ishihara K, Ago Y, Baba A, Matsuda T.
    J Pharmacol Exp Ther; 2007 Jul 30; 322(1):274-81. PubMed ID: 17429058
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 45.